161 related articles for article (PubMed ID: 16187972)
1. Within- and between- subject variability in methadone pharmacokinetics and pharmacodynamics in methadone maintenance subjects.
Hanna J; Foster DJ; Salter A; Somogyi AA; White JM; Bochner F
Br J Clin Pharmacol; 2005 Oct; 60(4):404-13. PubMed ID: 16187972
[TBL] [Abstract][Full Text] [Related]
2. Steady-state pharmacokinetics and pharmacodynamics in methadone maintenance patients: comparison of those who do and do not experience withdrawal and concentration-effect relationships.
Dyer KR; Foster DJ; White JM; Somogyi AA; Menelaou A; Bochner F
Clin Pharmacol Ther; 1999 Jun; 65(6):685-94. PubMed ID: 10391674
[TBL] [Abstract][Full Text] [Related]
3. Subjective and physiological responses among racemic-methadone maintenance patients in relation to relative (S)- vs. (R)-methadone exposure.
Mitchell TB; Dyer KR; Newcombe D; Salter A; Somogyi AA; Bochner F; White JM
Br J Clin Pharmacol; 2004 Dec; 58(6):609-17. PubMed ID: 15563359
[TBL] [Abstract][Full Text] [Related]
4. Major depressive disorder and patient satisfaction in relation to methadone pharmacokinetics and pharmacodynamics in stabilized methadone maintenance patients.
Elkader AK; Brands B; Dunn E; Selby P; Sproule BA
J Clin Psychopharmacol; 2009 Feb; 29(1):77-81. PubMed ID: 19142113
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic interaction between voriconazole and methadone at steady state in patients on methadone therapy.
Liu P; Foster G; Labadie R; Somoza E; Sharma A
Antimicrob Agents Chemother; 2007 Jan; 51(1):110-8. PubMed ID: 17074798
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and pharmacodynamics of methadone enantiomers after coadministration with fosamprenavir-ritonavir in opioid-dependent subjects.
Cao YJ; Smith PF; Wire MB; Lou Y; Lancaster CT; Causon RC; Bigelow GE; Martinez E; Fuchs EJ; Radebaugh C; McCabe S; Hendrix CW
Pharmacotherapy; 2008 Jul; 28(7):863-74. PubMed ID: 18576901
[TBL] [Abstract][Full Text] [Related]
7. Patterns of symptom complaints in methadone maintenance patients.
Dyer KR; White JM
Addiction; 1997 Nov; 92(11):1445-55. PubMed ID: 9519488
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of levo-alpha-acetylmethdol (LAAM) as an alternative treatment for methadone maintenance patients who regularly experience withdrawal: a pharmacokinetic and pharmacodynamic analysis.
Newcombe DA; Bochner F; White JM; Somogyi AA
Drug Alcohol Depend; 2004 Oct; 76(1):63-72. PubMed ID: 15380290
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic-pharmacodynamic modeling of mood and withdrawal symptoms in relation to plasma concentrations of methadone in patients undergoing methadone maintenance treatment.
Shiran MR; Lennard MS; Iqbal MZ; Lagundoye O; Seivewright N; Tucker GT; Rostami-Hodjegan A
J Clin Psychopharmacol; 2012 Oct; 32(5):666-71. PubMed ID: 22926601
[TBL] [Abstract][Full Text] [Related]
10. Fluctuations in (R,S)-methadone pharmacokinetics and response among long-term methadone maintenance patients.
Mitchell TB; Dyer KR; Newcombe D; Somogyi AA; White JM
Addict Biol; 2006 Jun; 11(2):170-4. PubMed ID: 16800831
[TBL] [Abstract][Full Text] [Related]
11. Population pharmacokinetics of (R)-, (S)- and rac-methadone in methadone maintenance patients.
Foster DJ; Somogyi AA; White JM; Bochner F
Br J Clin Pharmacol; 2004 Jun; 57(6):742-55. PubMed ID: 15151520
[TBL] [Abstract][Full Text] [Related]
12. Effect of lersivirine co-administration on pharmacokinetics of methadone in healthy volunteers.
Vourvahis M; Wang R; Gruener DM; Bruce RD; Haider S; Tawadrous M
Drug Alcohol Depend; 2012 Nov; 126(1-2):183-8. PubMed ID: 22682979
[TBL] [Abstract][Full Text] [Related]
13. Dolutegravir does not affect methadone pharmacokinetics in opioid-dependent, HIV-seronegative subjects.
Song I; Mark S; Chen S; Savina P; Wajima T; Peppercorn A; Bala U; Geoffroy P; Piscitelli S
Drug Alcohol Depend; 2013 Dec; 133(2):781-4. PubMed ID: 24018316
[TBL] [Abstract][Full Text] [Related]
14. Comparison of tincture of opium and methadone to control opioid withdrawal in a Thai treatment centre.
Jittiwutikarn J; Ali R; White JM; Bochner F; Somogyi AA; Foster DJ
Br J Clin Pharmacol; 2004 Nov; 58(5):536-41. PubMed ID: 15521902
[TBL] [Abstract][Full Text] [Related]
15. Alterations in methadone metabolism during late pregnancy.
Jarvis MA; Wu-Pong S; Kniseley JS; Schnoll SH
J Addict Dis; 1999; 18(4):51-61. PubMed ID: 10631963
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and pharmacodynamics of high doses of pharmaceutically prepared heroin, by intravenous or by inhalation route in opioid-dependent patients.
Rook EJ; van Ree JM; van den Brink W; Hillebrand MJ; Huitema AD; Hendriks VM; Beijnen JH
Basic Clin Pharmacol Toxicol; 2006 Jan; 98(1):86-96. PubMed ID: 16433897
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and pharmacodynamics of methadone enantiomers after coadministration with amprenavir in opioid-dependent subjects.
Hendrix CW; Wakeford J; Wire MB; Lou Y; Bigelow GE; Martinez E; Christopher J; Fuchs EJ; Snidow JW
Pharmacotherapy; 2004 Sep; 24(9):1110-21. PubMed ID: 15460171
[TBL] [Abstract][Full Text] [Related]
18. Comparative pharmacodynamics and pharmacokinetics of methadone and slow-release oral morphine for maintenance treatment of opioid dependence.
Mitchell TB; White JM; Somogyi AA; Bochner F
Drug Alcohol Depend; 2003 Oct; 72(1):85-94. PubMed ID: 14563546
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic interaction of nelfinavir and methadone in intravenous drug users.
Hsyu PH; Lillibridge J; Daniels E; Kerr BM
Biopharm Drug Dispos; 2006 Mar; 27(2):61-8. PubMed ID: 16299829
[TBL] [Abstract][Full Text] [Related]
20. Slow-release oral morphine for maintenance treatment of opioid addicts intolerant to methadone or with inadequate withdrawal suppression.
Kastelic A; Dubajic G; Strbad E
Addiction; 2008 Nov; 103(11):1837-46. PubMed ID: 19032534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
